» Articles » PMID: 26705566

Outcomes Following the Implantation of Cardioverter-defibrillator for Primary Prevention in Transposition of the Great Arteries After Intra-atrial Baffle Repair: a Single-centre Experience

Overview
Journal Europace
Date 2015 Dec 26
PMID 26705566
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: Patients with D-loop transposition of the great arteries (D-TGA) status post intra-atrial baffling are at an increased risk for sudden cardiac arrest. The benefit of primary implantable cardioverter-defibrillator (ICD) implantation in these patients is questionable due to high burden of adverse events. We aimed to evaluate the incidence and causes of all types of device shocks, as well as of device-related complications among patients with D-TGA implanted with ICDs for primary prevention.

Methods And Results: Retrospective analysis of all patients with D-TGA who underwent atrial switch procedure and ICD implantation for primary prevention. Eighteen patients (83% males) were identified. Average age at atrial switch was 2.5 years (range 0.1-17) and at ICD implantation 26 years (15-41). During a median follow-up of 4 years, 10 patients (55%) received shocks for non-ventricular arrhythmic events, whereas 1 patient was shocked for ventricular tachycardia, for an annual rate of shock delivery of 7.1%. The most common cause for shock delivery was the occurrence of atrial arrhythmias, mostly in the form of atrial flutter. Elevated systemic ventricular end-diastolic pressures were found to be associated with an increased risk for inappropriate shocks. Five patients (28%) required lead extraction and three required generator change due to device recalls during follow-up.

Conclusion: Atrial arrhythmias were the most common cause for ICD shocks in a primary prevention population, while ventricular tachycardia was infrequent. The association between elevated end-diastolic pressures and the occurrence of arrhythmias demonstrates the close mechano-electrical relationship in D-TGA and may be an important predictor of arrhythmic events.

Citing Articles

An unmet need: arrhythmia detection by implantable loop recorder in the systemic right ventricle.

Kakarla J, Crossland D, Murray S, Adhvaryu K, Jansen K, Rybicka J Europace. 2023; 25(11).

PMID: 37816150 PMC: 10634521. DOI: 10.1093/europace/euad304.


Advancing the science of management of arrhythmic disease in children and adult congenital heart disease patients within the last 25 years.

Paul T, Krause U, Sanatani S, Etheridge S Europace. 2023; 25(8).

PMID: 37622573 PMC: 10450816. DOI: 10.1093/europace/euad155.


Overview of Long-Term Outcome in Adults with Systemic Right Ventricle and Transposition of the Great Arteries: A Review.

Bevilacqua F, Pasqualin G, Ferrero P, Micheletti A, Negura D, DAiello A Diagnostics (Basel). 2023; 13(13).

PMID: 37443599 PMC: 10340263. DOI: 10.3390/diagnostics13132205.


Brazilian Guidelines for Cardiac Implantable Electronic Devices - 2023.

Teixeira R, Fagundes A, Baggio Junior J, Oliveira J, Medeiros P, Valdigem B Arq Bras Cardiol. 2023; 120(1):e20220892.

PMID: 36700596 PMC: 10389103. DOI: 10.36660/abc.20220892.


Narrative review of: risk stratification and implantable cardioverter-defibrillator therapy in adults with congenital heart disease.

Kobe J, Willy K, Eckardt L, Baumgartner H, Wasmer K Cardiovasc Diagn Ther. 2021; 11(2):538-549.

PMID: 33968632 PMC: 8102248. DOI: 10.21037/cdt-20-633.